Sage Journals: Discover world-class research

Abstract

Background:

Paediatric multiple sclerosis (pedMS) patients at a single site were shown to have reduced brain volumes and failure of age-expected brain growth compared to healthy controls. However, the precise time of onset of brain volume loss remains unclear.

Objective:

To longitudinally study brain volumes in a multi-centre European cohort at first presentation and after 2 years.

Methods:

Brain volumes of high-resolution magnetic resonance imaging (MRI) data from 37 pedMS patients at first presentation prior to steroid therapy and at 2-year follow-up (n = 21) were compared to matched longitudinal MRI data from the NIH Paediatric MRI Data Repository.

Results:

Patients showed significantly reduced whole brain, grey and white matter and increased ventricular volumes at initial presentation and at follow-up compared to controls. Over 2 years, patients exhibited significant reduction of whole brain and white matter volumes, accompanied by increased ventricular volume. Brain volume loss at follow-up correlated with a higher number of infratentorial lesions, relapses and an increased Expanded Disability Status Scale (EDSS) score.

Conclusions:

In pedMS patients, brain volume loss is present already at first clinical presentation and accelerated over 2 years. Increased disease activity is associated with more severe brain volume loss. MRI brain volume change might serve as an outcome parameter in future prospective pedMS studies.

Keywords

Paediatric multiple sclerosis magnetic resonance volumetry brain growth disease-modifying therapies

Get full access to this article

View all access options for this article.

References

Yeh

Weinstock-Guttman

Ramanathan

et al . Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain 2009; 132(Pt. 12): 3392–3400.

Waubant

Chabas

Okuda

et al . Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 2009; 66(8): 967–971.

Gorman

Healy

Polgar-Turcsanyi

et al . Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66(1): 54–59.

Renoux

Vukusic

Mikaeloff

et al . Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007; 356(25): 2603–2613.

Baruch

O’Donnell

Glanz

et al . Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis. Mult Scler 2016; 22(3): 354–361.

Kerbrat

Aubert-Broche

Fonov

et al . Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS. Neurology 2012; 78(3): 194–201.

Aubert-Broche

Fonov

Narayanan

et al . Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth. Neurology 2014; 83(23): 2140–2146.

Krupp

Tardieu

Amato

et al . International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler 2013; 19(10): 1261–1267.

Evans

AC.

The NIH MRI study of normal brain development. Neuroimage 2006; 30: 184–202.

10.

Schmidt

Bayesian inference for structured additive regression models for large-scale problems with applications to medical imaging. PhD Dissertation, Ludwig-Maximilians-Universität München, Munich, 2017.

11.

Battaglini

Jenkinson

De Stefano

Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012; 33(9): 2062–2071.

12.

Smith

Zhang

Jenkinson

et al . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17(1): 479–489.

13.

Smith

Jenkinson

Woolrich

et al . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23(Suppl. 1): S208–S219.

14.

Gout

Tourbah

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol 2014; 75(3): 463–449.

15.

Chataway

Schuerer

Alsanousi

et al . Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): A randomised, placebo-controlled, phase 2 trial. Lancet 2014; 383(9936): 2213–2221.

16.

Hauser

Bar-Or

Comi

et al . Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N Engl J Med 2017; 376(3): 221–234.

17.

Montalban

Hauser

Kappos

et al . Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med 2017; 376(3): 209–220.

18.

De Stefano

Giorgio

Battaglini

et al . Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology 2010; 74(23): 1868–1876.

19.

Azevedo

Overton

Khadka

et al . Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm 2015; 2(3): e102.

20.

Chard

Griffin

Parker

GJM

et al . Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125(Pt. 2): 327–337.

21.

Tiberio

Chard

Altmann

et al . Gray and white matter volume changes in early RRMS: A 2-year longitudinal study. Neurology 2005; 64(6): 1001–1007.

22.

Sanfilipo

Benedict

RHB

Sharma

et al . The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction. Neuroimage 2005; 26(4): 1068–1077.

23.

Gaetano

Haring

Radue

et al . Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis. Neurology 2018; 90(15): e1324–e1332.

24.

Aubert-Broche

Weier

Longoni

et al . Monophasic demyelination reduces brain growth in children. Neurology 2017; 88(18): 1744–1750.

25.

Longoni

Brown

MomayyezSiahkal

et al . White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders. Brain 2017; 140(5): 1300–1315.

26.

Ghassemi

Narayanan

Banwell

et al . Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis. PLoS ONE 2014; 9(2): e85741.

27.

Huppke

Ellenberger

Rosewich

et al . Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol 2014; 21(3): 441–446.

28.

Daams

Steenwijk

Wattjes

et al . Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis. Neurology 2015; 85(3): 248–255.

29.

Minneboo

Barkhof

Polman

et al . Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004; 61(2): 217–221.

30.

Tintore

Rovira

Arrambide

et al . Brainstem lesions in clinically isolated syndromes. Neurology 2010; 75(21): 1933–1938.

31.

Chard

Brex

Ciccarelli

et al . The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: A 14 year follow up study. J Neurol Neurosurg Psychiatry 2003; 74(11): 1551–1554.

32.

Radue

E-W

Barkhof

Kappos

et al . Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis. Neurology 2015; 84(8): 784–793.

33.

Zivadinov

Reder

Filippi

et al . Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology 2008; 71(2): 136–144.

34.

Verhey

Signori

Arnold

et al . Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials. Neurology 2013; 81(14): 1215–1221.

35.

Waldman

Ghezzi

Bar-Or

et al . Multiple sclerosis in children: An update on clinical diagnosis, therapeutic strategies, and research. Lancet Neurol 2014; 13(9): 936–948.

36.

Banwell

Arnold

Tillema

J-M

et al . MRI in the evaluation of pediatric multiple sclerosis. Neurology 2016; 87(9 Suppl. 2): S88–S96.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.10 MB

Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure

Abstract

Background:

Objective:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References

Supplementary Material